In a research report released Friday, Roth Capital analyst Chris Lewis reiterated a Neutral rating on shares of EXACT Sciences Corporation (NASDAQ:EXAS), while raising the …
Both Relypsa Inc (NASDAQ:RLYP) and EXACT Sciences Corporation (NASDAQ:EXAS) received good news about their flagship products this week. Relypsa announced May prescription data …
EXACT Sciences Corporation Exact shares rallied yesterday on an apparent leaked JAMA article unveiling that USPSTF highly recommends colon cancer screening from age …
In a research report published Wednesday, Roth Capital analyst Chris Lewis reiterated a Neutral rating on shares of EXACT Sciences Corporation (NASDAQ:EXAS), with …
EXACT Sciences Corporation (NASDAQ:EXAS) announced that under a recently-signed contract, Exact Sciences is now an in-network provider of Cologuard with Anthem Blue Cross and …
Digestive Disease Week, an annual gathering of physicians and researchers in the fields of gastrointestinal surgery, hepatology, endoscopy, and gastroenterology, took place last …
Analysts weigh in on drug makers Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Synergy Pharmaceuticals Inc (NASDAQ:SGYP), and EXACT Sciences Corporation (NASDAQ:EXAS). While Valeant just hosted an investor …
EXACT Sciences Corporation (NASDAQ: EXAS) announced that the company reported revenues of $39.4 million as a result of completing more than 104,000 Cologuard …
EXACT Sciences Corporation (NASDAQ:EXAS) announced the appointment of John K. Bakewell as chief financial officer.
EXACT Sciences Corporation (NASDAQ:EXAS) announced that the Centers for Medicare and Medicaid Services (CMS) indicated that it is correcting the 2016 Clinical Laboratory Fee …
